- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 10.4M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 21.18M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 476.84K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $21K |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $6.93M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $10.79M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $40.27M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $47.72M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$145.8K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$202.61K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.23M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.27M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.95M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.17M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $37.59M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $42.77M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $45.22M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $52.89M |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.36 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$5.12 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.91M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.83M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$7.71M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.44M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$7.73M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.29M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $6.77K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $45.12K |
| Revenue | Q1 2026 · Mar 31, 2026 | $35.31K |
| Revenue | Q1 2026 · Mar 31, 2025 | $110.31K |